These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28476276)

  • 1. The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.
    Zweben A; Piepmeier ME; Fucito L; O'Malley SS
    J Subst Abuse Treat; 2017 Jun; 77():72-78. PubMed ID: 28476276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit.
    Toll BA; McKee SA; Martin DJ; Jatlow P; O'Malley SS
    Nicotine Tob Res; 2007 May; 9(5):597-605. PubMed ID: 17454716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.
    McCarthy DE; Versella MV
    Nicotine Tob Res; 2019 Oct; 21(11):1488-1495. PubMed ID: 30107419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to varenicline in the COMPASS smoking cessation intervention trial.
    Catz SL; Jack LM; McClure JB; Javitz HS; Deprey M; Zbikowski SM; McAfee T; Richards J; Swan GE
    Nicotine Tob Res; 2011 May; 13(5):361-8. PubMed ID: 21350041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot clinical trial of varenicline for smoking cessation in black smokers.
    Nollen NL; Cox LS; Nazir N; Ellerbeck EF; Owen A; Pankey S; Thompson N; Ahluwalia JS
    Nicotine Tob Res; 2011 Sep; 13(9):868-73. PubMed ID: 21498427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report.
    Buchanan TS; Berg CJ; Cox LS; Nazir N; Benowitz NL; Yu L; Yturralde O; Jacob P; Choi WS; Ahluwalia JS; Nollen NL
    Nicotine Tob Res; 2012 Sep; 14(9):1083-91. PubMed ID: 22367976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-related disease factors and smoking cessation treatment: Analysis of an ongoing clinical trial.
    Carroll AJ; Veluz-Wilkins AK; Blazekovic S; Kalhan R; Leone FT; Wileyto EP; Schnoll RA; Hitsman B
    Psychooncology; 2018 Feb; 27(2):471-476. PubMed ID: 28636795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of Adherence to Varenicline Among HIV+ Smokers.
    Shelley D; Tseng TY; Gonzalez M; Krebs P; Wong S; Furberg R; Sherman S; Schoenthaler A; Urbina A; Cleland CM
    Nicotine Tob Res; 2015 Aug; 17(8):968-74. PubMed ID: 26180221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
    Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
    Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.
    O'Malley SS; Zweben A; Fucito LM; Wu R; Piepmeier ME; Ockert DM; Bold KW; Petrakis I; Muvvala S; Jatlow P; Gueorguieva R
    JAMA Psychiatry; 2018 Feb; 75(2):129-138. PubMed ID: 29261824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pragmatic Randomized Trial Comparing Telephone-Based Enhanced Pharmacy Care and Usual Care to Support Smoking Cessation.
    Gong J; Baker CL; Zou KH; Bruno M; Jumadilova Z; Lawrence D; Wilson B; Ewel C
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1417-1425. PubMed ID: 27882838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to varenicline and associated smoking cessation in a community-based patient setting.
    Liberman JN; Lichtenfeld MJ; Galaznik A; Mastey V; Harnett J; Zou KH; Leader JB; Kirchner HL
    J Manag Care Pharm; 2013 Mar; 19(2):125-31. PubMed ID: 23461428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
    Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
    Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
    Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
    Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; McDermott MS; Lindson-Hawley N; Vogt F; Farley A; Aveyard P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009164. PubMed ID: 25914910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
    Peng AR; Schnoll R; Hawk LW; Cinciripini P; George TP; Lerman C; Tyndale RF
    Drug Alcohol Depend; 2018 Sep; 190():72-81. PubMed ID: 29986268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.
    Roberts W; Shi JM; Tetrault JM; McKee SA
    J Addict Med; 2018; 12(3):227-233. PubMed ID: 29438157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
    JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.